Who invested in Aileron Therapeutics?
Aileron Therapeutics's investors include Novartis Venture Fund, Apple Tree Partners, SR One, Roche Venture Fund and Excel Venture Management, and 4 more on record.
United States · Series E startup
7 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$140Mraised across 7 rounds since 2006, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $20M sold, first sale Oct 2014
Reported by finsmes.comSEC filing: $15M sold, first sale Nov 2013
Reported by finsmes.com
Reported by zibb.comSEC filing: $28M sold, first sale May 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Aileron Therapeutics's investors include Novartis Venture Fund, Apple Tree Partners, SR One, Roche Venture Fund and Excel Venture Management, and 4 more on record.
Aileron Therapeutics has raised $140M across 7 rounds since 2006.
Aileron Therapeutics's most recent round was a Series E of $33M in Oct 2014.
Aileron Therapeutics's largest round on record is $40M (Series D), in Jun 2009.
Aileron Therapeutics's first round on record, in Dec 2006, was backed by Novartis Venture Fund and Apple Tree Partners.
Aileron Therapeutics's latest named round is a Series E, in Oct 2014.
Aileron Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.